ANGEL LUIS
GUERRERO PERAL
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublications en collaboration avec des chercheurs de Hospital Clínico Universitario Lozano Blesa (19)
2024
-
Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
Frontiers in Neurology , Vol. 15
-
RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine
European Journal of Neurology, Vol. 31, Núm. 4
2023
-
Diagnosis and treatment of trigeminal neuralgia: Consensus statement from the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 38, pp. S37-S52
-
Evaluating the Impact of a Training Program in Shared Decision-Making for Neurologists Treating People with Migraine
Neurology and Therapy, Vol. 12, Núm. 4, pp. 1319-1334
-
Recomendaciones de consenso para el tratamiento de la prevención de la migraña
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. 246-253
-
Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 38, Núm. 9, pp. 635-646
-
[Translated article] Consensus recommendations on the preventive treatment of migraine
Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. T246-T253
2022
-
Adaptation and Validation of the Spanish Version of Decisional Conflict Scale in People with Migraine in Spain
Patient Preference and Adherence, Vol. 16, pp. 3291-3302
-
Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Neurologia, Vol. 37, Núm. 5, pp. 390-402
2021
-
1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress
Revista de Neurologia
-
Document of revision and updating of medication overuse headache (MOH)
Neurologia, Vol. 36, Núm. 3, pp. 229-240
2020
-
Evaluation of the concomitant use of oral preventive treatments and onabotulinumtoxinA in chronic migraine: the PREVENBOX study
European Journal of Neurology, Vol. 27, Núm. 10, pp. 2102-2108
-
Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
Neurologia, Vol. 35, Núm. 8, pp. 568-578
-
Impact of the COVID-19 pandemic on headache management in Spain: an analysis of the current situation and future perspectives
Neurologia, Vol. 35, Núm. 6, pp. 372-380
2019
-
Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice
Neurologia, Vol. 34, Núm. 6, pp. 408-417
-
Real world preventative drug management of migraine among Spanish neurologists
Journal of Headache and Pain, Vol. 20, Núm. 1
2018
-
Patterns of anaesthetic pericranial nerve block in headache patients
Neurologia, Vol. 33, Núm. 3, pp. 160-164
2016
-
Personality traits in patients with cluster headache: a comparison with migraine patients
Journal of Headache and Pain, Vol. 17, Núm. 1